Thymic epithelial cells are an important source of cytokines and other regulatory peptides which guide thymocyte proliferation and maturation. Parathyroid hormone-related protein (PTHrP), a cytokine-like peptide, has been reported to affect the proliferation of lymphocytes in vitro. The studies presented here were undertaken to test the hypotheses that PTHrP is produced locally within the thymus where it could influence thymocyte maturation and, more specifically, that thymic epithelial cells (TEC) could be the intrathymic source of PTHrP expression. To this end, immunohistochemical studies were performed to localise PTHrP and the PTH\PTHrP receptor within the adult rat thymus. Antibodies directed against 2 different PTHrP epitopes, PTHrP(1-34) and PTHrP(34-53), demonstrated prominent specific PTHrP immunoreactivity in both subcapsular and medullary TEC. In addition, faint but specific staining for PTHrP was seen in the cortex, interdigitating between cortical lymphocytes while sparing epithelial-free subcapsular areas, thus suggesting that cortical TEC could also be a source of PTHrP immunoreactivity. In contrast, PTH\PTHrP receptor immunoreactivity was only seen in medullary and occasional septal TEC ; no evidence of cortical or lymphocytic PTH\PTHrP receptor immunoreactivity was detected. Immunohistochemical studies of cultured cytokeratin-positive rat TEC confirmed the results of these in situ studies as cultured TEC were immunoreactive both for PTHrP and the PTH\PTHrP receptor. Thus these results demonstrate that PTHrP is produced by the epithelial cells of the mature rat thymus. This suggests that PTHrP, a peptide with known cytokine, growth factor and neuroendocrine actions, could exert important intrathymic effects mediated by direct interactions with TEC, or indirect effects on PTH\PTHrP receptor-negative thymocytes.
The thymus plays a critical role in the development of cellular immunity, providing the necessary microenvironment for the proliferation, maturation, and selection of self-tolerant T cells (Ritter & Crispe, 1992) . Congenital defects in thymic development, as occurs in humans with DiGeorge syndrome, results in serious impairment of the immune response (Couly et al. 1983 ). The thymic stroma and, in particular, thymic epithelial cells (TEC) are responsible for delivering the necessary signals for orderly T cell Correspondence to Dr Janet L. Funk, Endocrinology, Box 24-5021, Arizona Health Sciences Center, Tucson, Arizona 85724, USA. Tel. : j1 520 626 3242 ; fax : j1 520 626 8110 ; e-mail : jfunk!u.arizona.edu development (Kendall, 1991 ; Anderson & Jenkinson, 1997) . Similarly, developing T cells are also critical for the development and maintenance of normal TEC functioning (Ritter & Boyd, 1993) . Animal models providing evidence for this important cross talk between TEC and thymocytes include SCID mice which have a primary defect in thymic ectodermal development that results in a lack of maturation of thymocytes, and nude mice which have a primary defect in T cell receptor expression that also results in abnormal TEC development (Shores et al. 1991 ; Nehls et al. 1996) . Indeed the aforementioned DiGeorge syndrome and experimentally induced hypo-or athymic conditions may also result from a primary defect in the development of the thymic neuroectodermal stroma, thus emphasising the importance of the thymic stroma in T cell development (Couly et al. 1983 : Manley & Capecchi, 1995 .
Studies suggest that TEC communicate with thymocytes in a paracrine fashion through the release of cytokines, such as IL-1 and IL-6 (Ritter & Boyd, 1993) . The importance of cytokines in thymocyte development has been shown, in part, by in vitro studies demonstrating their ability to act as mitogens or comitogens in stimulating thymocyte proliferation (Le & Singer, 1993) . Parathyroid hormone-related protein (PTHrP), a more recently discovered peptide that binds to and activates the parathyroid hormone(PTH)\PTHrP receptor, has also been reported to inhibit simulated proliferation of T-cell enriched peripheral lymphocytes (Adachi et al. 1990) . While the effects of PTHrP on thymocyte proliferation have not, to our knowledge, been reported, an older body of literature predating the discovery of PTHrP suggests that PTH, presumably acting via the same PTH\PTHrP receptor, stimulates thymocyte proliferation while demonstrating variable effects on the proliferation of PHA-stimulated peripheral lymphocytes (Whitfield et al. 1970 ; Hoette et al. 1977 ; Atkinson et al. 1987 ; Elias et al. 1988 ; Shasha et al. 1988 ; Klinger et al. 1990) .
PTHrP was initially discovered because of its ability to cause humoral hypercalcaemia of malignancy when produced in large amounts by certain tumours (Rankin et al. 1997) . In this setting, high circulating levels of PTHrP act in an endocrine fashion via the PTH\PTHrP receptor in kidney and bone, classic sites of PTH action, to inhibit renal calcium clearance and stimulate calcium mobilisation from the skeleton (Rankin et al. 1997) . Subsequent studies have shown that this ubiquitous peptide, which is highly conserved among species, normally acts locally in an autocrine or paracrine fashion at its many sites of production (Philbrick et al. 1996 ; Rankin et al. 1997) . Binding of N-terminal containing PTHrP to the PTH\PTHrP receptor, which is expressed in many organs in addition to kidney and bone, leads to actions as diverse as stimulation of cell differentiation or relaxation of smooth muscle (Philbrick et al. 1996) . Thus in the absence of malignancy, PTHrP more closely follows a cytokine\growth factor paradigm of expression and action rather than acting as a systemic hormone. In addition, prior studies have suggested that PTHrP shares other characteristics of cytokines, functioning as a member of the cytokine cascade that is produced in response to inflammation, with TNF and IL-1 inducing PTHrP expression, while PTHrP stimulates production of IL-6 (Funk et al. 1993 Trout et al. 1997) .
Given these cytokine-like characteristics of PTHrP, as well as reports of its effects on T cell proliferation, we therefore hypothesised that PTHrP could be produced locally within the thymus where it could influence thymocyte maturation in a fashion analogous to TEC-derived IL-1 or IL-6 (Ritter & Boyd, 1993) . A prior study of splenic PTHrP expression in rodents by Funk et al (1995) demonstrated PTHrP expression in the splenic stroma, but not in splenic lymphocytes. Although the stroma of the thymus, unlike other lymphoid organs such as the spleen, is believed to be of ectodermal or endodermal rather than mesenchymal origin , we hypothesised that the thymic stroma and, in particular, cytokine-producing TEC would be a primary source of intrathymic PTHrP in the mature thymus. Consistent with this hypothesis, there is one prior report of PTHrP expression in the medullary reticuloepithelial cells of human fetal thymus (Kramer et al. 1991) . However, in that study, fetal age is not reported, thus leaving unanswered questions regarding the relationship of thymic PTHrP expression to the developmental stage of thymic maturation and function.
The studies presented here were undertaken to determine whether PTHrP is expressed in mature, fully developed thymus. Immunohistochemical techniques were used to identify sites of PTHrP expression in adult rat thymus using 2 different antibodies directed against PTHrP. Additionally, to determine intrathymic targets for PTHrP action, sites of expression of the PTH\PTHrP receptor were also characterised. Results of these in situ immunohistochemical experiments were confirmed by in vitro studies using well characterised rat thymic epithelial cells to evaluate expression of PTHrP and its receptor (Kurz et al. 1996) .
  

Immunohistochemistry of rat thymus
Thymuses, removed from 6-8 wk Porton Wistar rats (Babraham Institute), were cut into 5-8 mm pieces and frozen using isopentane over liquid nitrogen before storage at k70 mC prior to sectioning. Freshly cut, acetone fixed (5 min\room temperature), 5 µm sections were blocked with 1 % BSA\1 % casein (A7906 and C7290, Sigma, Dorset, UK) in PBS for 1 h at room temperature for pancytokeratin, HIS 39, or PTHrP(1-34) antibody staining, or, using an alternative protocol (Funk et al. 1998) , for 2 h with 40 % goat serum in PBS for PTHrP(34-53) or the PTH\PTHrP receptor. Sections were then incubated overnight at 4 mC with the following dilutions of primary antibody (in PBS) : 1 : 500 dilution of mouse monoclonal anticytokeratin antibodies (pan cytokeratin, Sigma C 2562) ; 1 : 200 dilution of mouse ascites containing HIS 39 monoclonal antibody which was a kind gift from Dr J. Kampinga of the University of Groningen, The Netherlands ; or a 1 : 500 dilution of rabbit antiserum directed against PTHrP(1-34) which was a kind gift from Dr W. Ratcliffe of the Wolfson Research Laboratory, Birmingham UK. Alternatively, sections were incubated for 3 d at 4 mC with the following primary antibodies (diluted in PBS containing 10 % goat serum) : 2.3 µg\ml affinity purified rabbit polyclonal antibody generated against human PTHrP(34-53) (Oncogene Science, Cambridge, MA) or 9-10 µg\ml affinity purified rabbit polyclonal antibody raised against an extracellular portion of the rat receptor (amino acids 90-106) (antibody and antigen kindly provided by Dr Robert Nissenson, UC San Francisco, CA). Following quenching of endogenous peroxidase in 0.5 % hydrogen peroxide in methanol, sections were then reblocked with 20 % rabbit serum (for mouse monoclonal primary antibodies) or goat serum (for rabbit primary antibodies) before incubation with secondary antibody. For all antibodies, except PTHrP(1-34), sections were then incubated for 90 min at room temperature with a 1 : 40 dilution (in PBS containing 10 % rat serum) of horseradish peroxidase (HRP)-rabbit antimouse IgG antibody (Dako P161) or HRPgoat antirabbit IgG antibody (Dako P0448). Sigma fast nonenhanced DAB (Sigma D4168) was used to visualise HRP staining. For sections incubated with PTHrP(1-34) antibody, sections were incubated with a 5 nm gold conjugated antirabbit IgG antibody (British Biocell International, Cardiff, UK), followed by silver enhancement according to the recommended protocol (SE100, Sigma). All sections, following dehydration, were mounted in Biomount (British BioCell International, Cardiff, UK). Specificity of cytokeratin or HIS 39 staining was determined by comparison with the absence of staining seen on sections where the primary antibody was omitted. Specificity of staining for PTHrP(1-34), PTHrP(34-53), or the receptor was confirmed by the absence of staining that resulted when cells were treated (1) with primary antibody that had been preincubated overnight at 4 mC with 75 µg\ml PTHrP(1-34) peptide (Penninsula Laboratories Europe, Merseyside, UK), a 50-fold excess by weight of PTHrP(34-53) peptide (Oncogene Science, Cambridge, MA), or a 25-fold excess by weight of PTH\PTHrP receptor peptide, respectively, or (2) with an equivalent dilution of rabbit serum or IgG.
Isolation and culture of rat thymic epithelial cells
Thymic epithelial cells were prepared using a modification of a previously described method (Kurz et al. 1996 ; Botham et al. unpublished results) . Thymuses from 5-6 wk male Porton Wistar rats (Babraham Institute) were removed and placed into serum free DMEM\F12 media (Gibco) containing penicillin (100 U\ml), streptomycin (100 µg\ml) and amphotericin (100 U\ml). The thymic capsule and associated blood vessels were removed and the thymic lobes separated, washed with fresh media and sliced into approximately 1 mm$ fragments. The fragments, after washing several times with fresh media, were transferred into media-free cell culture flasks for 3 h to allow the fragments to attach to the base of the flask. After this period, the fragments were incubated in DMEM\F12 supplemented with the following constituents (obtained from Sigma, Dorset, UK, unless otherwise stated) : 30 % horse serum, transferrin (25 µl\ml), -glutamine (2 m), EGF-1 (10 ng\ml), insulin (5 µg\ml) cholera toxin (1 ng\ml), penicillin (100 U\ml), streptomycin (100 µg\ml) and amphotericin (100 U\ml, Gibco, Paisley, Scotland). After 2 wk, with renewal of media 3 times a week, the cultures were treated with EDTA\trypsin solution to remove fibroblasts. When confluent monolayers were established, the serum content was reduced to 10 % and cells were passaged on a weekly basis using Cell Dissociation Fluid (Sigma, Dorset, UK).
Immunocytochemistry of thymic epithelial cells
Subculture 10 TEC were replated onto 2.5 µg\ml poly--lysine coated sterile coverslips 1 or 2 d before staining. On the day of staining, cells were rinsed in PBS and fixed with 95 % ethanol (5 min). Cells were blocked for 1 h at room temperature with 0.5 % casein\BSA in PBS (for cytokeratin) or 40 % goat serum in PBS (for PTHrP and receptor) before overnight incubation at 4 mC with primary antibodies (1 : 500 dilution of mouse monoclonal anticytokeratin antibodies in PBS ; 1.2 µg\ml human PTHrP(34-53) antibody or 5 µg\ml rat receptor antibody in 10 % goat serum). Cells were blocked again for 30 min with 20 % rabbit or goat sera before further incubation at room temperature for 3 h (cytokeratin) or 90 min (PTHrP and receptor) with the appropriate secondary antibody (1 : 80 dilution of horseradish peroxidase (HRP)-rabbit antimouse IgG ; 1 : 40 dilution of HRPgoat antirabbit IgG antibody). Secondary antibodies were visualised and cells mounted as described for tissue staining. Specificity of cytokeratin staining was determined by comparison with staining of cells where the primary antibody was omitted. Specificity of staining for PTHrP or the receptor was confirmed by the absence of staining that resulted when cells were treated with (1) primary antibody preincubated overnight at 4 mC with a 50-fold or 25-fold excess by weight of the respective peptide antigen, or (2) an equivalent concentration of rabbit IgG.

Immunohistochemical staining of thymus using antibody directed against PTHrP(1-34)
Specific immunoreactivity for PTHrP(1-34), as determined by the absence of staining when the primary antibody was preabsorbed with an excess of antigen, was seen most prominently in subcapsular TEC lining the basement membrane of the thymic capsule and in medullary cells (Fig. 1 a) . At the cortical\medullary junction, there was also a specific, fine reticular pattern for PTHrP(1-34) staining between cortical lymphocytes, in addition to the more prominent staining of medullary TEC, as identified by their large perikarya and short stubby processes (Fig. 1 b) . Because of the difficulty in identifying distinct cortical TEC in these frozen sections, comparisons were made of the cortico-medullary staining pattern for PTHrP(1-34) and cytokeratin staining of cortical and medullary TEC. The results suggest that cortical PTHrP immunoreactivity could be present in cortical TEC (Fig. 1 b, c) .
Immunohistochemical staining of thymus using antibody directed against PTHrP(34-53)
A similar pattern of thymic PTHrP immunoreactivity was also seen using antibody directed against the PTHrP(34-53) epitope. Medullary TEC (Fig. 2 a) and subcapsular epithelial (Fig. 3 a) , identified by their location and morphology, as well as by comparison with His 39 staining on sequential sections (Figs 2 b,  3 c) , were immunoreactive for PTHrP(34-53). Specific staining was also seen in the cortex in an interdigitating pattern surrounding cortical lymphocytes (Fig. 3 a, b) . The cortical pattern of PTHrP(34-53) immunoreactivity enveloped a majority of the outer cortical thymocytes (Fig. 3 a) , while staining on sequential sections using pancytokeratin antibody revealed a more discrete distribution of cytokeratin immunoreactivity in cortical TEC that did not encompass all lymphocytes (Fig. 3 d ) . The absence of staining for both PTHrP (Fig. 3 a) and cytokeratin (Fig. 3 d ) in epithelial-free areas of cortex located below the subcapsular area suggests that cortical lymphocytes were not immunoreactive for PTHrP.
Immunohistochemical staining of thymus using antibody directed against PTH\PTHrP receptor
Medullary TEC, identified by their morphology and location, as well as by comparison with His-39 staining on sequential sections (Fig. 4 b) , were the primary site of specific PTH\PTHrP receptor immunoreactivity seen in the thymus (Fig. 4 a) . Faint but specific immunoreactivity was also noted in a few septal lining cells (data not shown). No immunoreactivity for the PTH\PTHrP receptor was detected in the cortex.
Immunohistochemical staining of thymic epithelial cells in culture using antibodies directed against PTHrP(34-53) and the PTH\PTHrP receptor
To confirm PTHrP and PTH\PTHrP expression in TEC, in vitro immunohistochemical studies were carried out in cultured TEC. The isolated cultured cells studied were cytokeratin-positive, thus verifying their identity as TEC (Fig. 5 a) . TEC in culture showed diffuse but granular cytoplasmic staining with PTHrP(34-53) antibody that was most prominent in the perinuclear area (Fig. 5 b) . Permeabilised TEC also stained specifically for the PTH\PTHrP receptor, demonstrating a fine reticular pattern of staining that was also most prominent in the perinuclear area (Fig.  5 c) .

The PTHrP peptide, which spans 141 amino acids in the rat, is posttranslationally processed into N-terminal, mid region, and C-terminal peptides (Philbrick et al. 1996) . N-terminal PTHrP peptides exert their biological effects via binding and activation of the PTH\PTHrP receptor, a ubiquitous receptor that has a similar binding affinity for PTH and PTHrP, 2 peptides that are thought to have been derived from a common ancestral gene (Philbrick et al. 1996) . PTH\PTHrP receptors are coupled to Gproteins and activate adenylyl cyclase\cAMP\protein kinase A and\or phosphoinositol\intracellular calcium\protein kinase C signalling pathways (Philbrick et al. 1996) . Midregion and C-terminal PTHrP peptides have also been shown to be biologically active, although no receptors have yet been identified for these peptides (Philbrick et al. 1996) .
The studies presented here demonstrate expression of N-terminal and midregion epitopes for PTHrP, as well as an epitope corresponding to an extracellular portion of the PTH\PTHrP receptor, in adult rat TEC both in situ and in culture. These studies therefore suggest that locally produced N-terminal containing PTHrP peptides may act in an autocrine fashion via binding to the PTH\PTHrP receptor and could, therefore, affect TEC function. Although in vitro studies demonstrating PTH binding to peripheral lymphocytes and PTH\PTHrP effects on thymocyte or peripheral lymphocyte proliferation suggest the possibility that thymocytes may also express PTH\PTHrP receptors (Whitfield et al. 1970 ; Hoette et al. 1977 ; Bialasiewicz et al. 1979 ; Yamamoto et al. 1983 ; Perry et al. 1984 ; Atkinson et al. 1987 ; Elias et al. 1988 ; Shasha et al. 1988 ; Adachi et al. 1990 ; Klinger et al. 1990) , no evidence of thymocyte PTH\PTHrP receptor immunoreactivity was found in these in situ studies. This suggests either that thymocytes do not express the PTH\PTHrP receptor in vivo, or, alternatively, that the immunohistochemical methods used here were not sensitive enough to detect receptor expression in these cells. Similarly, although there has been one report of N-terminal PTHrP release from mitogen-stimulated peripheral lymphocytes in vitro (Adachi et al. 1990) , in addition to a large literature on PTHrP expression by transformed lymphocytes, such as HTLV-1-infected T cells (Motokura et al. 1988 ; Philbrick et al. 1996) , no evidence of PTHrP staining of thymocytes was seen in thymic sections. These results are consistent with the results of in vivo splenic PTHrP localisation studies in rats where no evidence of PTHrP expression was found in the lymphocyte fraction of the spleen by immunohistochemical or Northern analysis (Funk et al. 1995) .
TEC can be divided into 6 groups, based on morphological and staining criteria (Van deWingaert et al. 1984 ; Ritter & Crispe, 1992) : flat type I cells which line the basement membrane of the thymic capsule as well as the septa and cortical perivascular spaces ; type 2-4 cells, identified by variations in electron density, which are located within the cortex and have a dendritic morphology with slender processes ; type 5 cells, a poorly differentiated epithelial cell present in very small numbers within the medulla ; and type 6 cells (which may be heterogeneous), the most abundant medullary TEC, which are characterised by abundant cytoplasm and short blunt processes. Both PTHrP and the PTH\PTHrP receptor were localised in our in situ studies to type I and type 6 cells of the rat thymus. Additionally, cultured TEC, which have phenotypic characteristics of subcapsular and medullary cells (Kurz et al. 1996 ; Head et al. 1997) , also were immunoreactive for PTHrP and its receptor. Colocalisation of PTHrP peptide and receptor on these cells is of particular interest since type I and type 6 cells, which also share common cell markers (CTES group II antibodies) (Kampinga et al. 1989) , contain secretory granules and release thymulin as well as other thymus-derived circulating hormones (Kendall & Stebbings, 1994 ; Schuurman et al. 1997) . PTHrP is therefore expressed in the subset of TECs which are thought to comprise the endocrine thymus (Kendall & Stebbings, 1994) .
In addition to PTHrP expression in type 1 and type 6 TEC, faint but specific PTHrP immunoreactivity was seen diffusely surrounding cortical lymphocytes, while no staining was seen in epithelial-free areas of cortex below the capsule. It is doubtful that cortical PTHrP immunoreactivity could be attributed to PTHrP staining of fibres such as collagen since collagen is predominantly restricted to septal regions in the medulla (Savino et al. 1993) . Macrophages are often present in the cortex, but these are easily identifiable by their morphology . Thus, although cortical epithelial extensions can be so fine that ultrastructural studies would be needed to confirm their immunoreactivity with these antibodies, cortical epithelial cells remain the most likely site of cortical PTHrP immunoreactivity. However, there was still a difference between cytokeratin staining of cortical TEC and cortical PTHrP immunoreactivity since the latter was more diffuse. This disparity suggests either that PTHrP immunoreactivity was present in structures other than or in addition to cortical TEC, or that there was a differential localisation of PTHrP vs cytokeratin in the interdigitating fine reticular processes of cortical TEC. In support of this latter explanation, the cortical PTHrP staining pattern seen here is very similar to that reported in the mouse for neuropeptides, such as oxytocin, which have been found in cortical nurse cells, a type of TEC that engulfs developing lymphocytes (Geenen et al. 1988) . Indeed, the entire thymic pattern of staining for neuropeptides, which exhibit strong expression in clearly identifiable subcapsular and medullary TEC in addition to a diffuse staining pattern between individual cortical thymocytes, is very similar to that reported here for PTHrP (Geenen et al. 1988 ; Schuurman et al. 1997) . Consistent with a possible colocalisation of PTHrP and other known neuropeptides, it must also be noted that PTHrP is itself a neuropeptide that is expressed by neurons as well as glial cells (Ono et al. 1997 ; Trout et al. 1997) . A recent report of PTHrP over-expression by a thymic carcinoid tumour, one of two case reports to date of dysregulated PTHrP expression in thymic tumours, further emphasises a potential neuroendocrine role for thymic PTHrP (Yoshikawa et al. 1994 ; Suzuki et al, 1998) .
TEC, in addition to their obvious similarities to and possible derivation from neuroectodermal cells (Jones et al. 1999 ) have also been postulated to have similarities with the cells of the epidermis (DeWaal & Rademakers, 1997) . It is therefore not surprising that PTHrP, in addition to being expressed in TEC, is also expressed by cells in all layers of the epidermis, as well as in cultured keratinocytes (Atillasoy et al. 1991 ; Philbrick et al. 1996) . Indeed, squamous epithelial cell carcinomas, including squamous carcinomas of the skin, are a common source of PTHrP overexpression in humoral hypercalcaemia of malignancy (Philbrick et al. 1996) .
While the intrathymic roles of TEC-derived hormones and\or neuropeptides are poorly understood at present, the intrathymic production of cytokines, such as IL-1 and IL-6, by TEC and other cells is thought to drive the development and maturation of thymocytes, as well as TEC (Carding et al. 1991 ; Ritter & Boyd, 1993 ; Meilin et al. 1995) . For example, cytokines induce cell proliferation and the expression of other locally acting cytokines in both thymocytes and TEC, as well as the expression of MHC II in TEC (Carding et al. 1991 ; Ritter & Crispe, 1992 ; Ritter & Boyd, 1993 ; Meilin et al. 1995) . PTHrP, a cytokine-like peptide that has been shown in other cell types to be regulated by IL-1 and to stimulate IL-6 production (Lowik et al. 1989 ; Casey et al. 1993 ; Funk et al. 1993 Funk et al. , 1994 Funk et al. , 1998 Ferguson et al. 1995 ; Trout et al. 1997) , may therefore act directly in an autocrine fashion on PTH\PTHrP receptorexpressing TEC to affect cell proliferation and\or cytokine secretion. Additionally, PTHrP may also exert indirect effects on PTH\PTHrP receptor-negative thymocytes via the stimulated secretion of TEC cytokines, such as IL-6, which can bind to and affect thymocyte function (Le et al. 1990) . A similar indirect effect on thymocyte maturation has also be proposed for other TEC-produced cytokines, such as leukaemia inhibitory factor (LIF) (Schluns et al. 1997) .
In summary, the results of the immunohistochemical studies reported here clearly demonstrate the expression of PTHrP, a peptide with neuroendocrine, growth factor, and cytokine-like properties, within the mature thymic epithelium. Furthermore, colocalisation of this multifunctional peptide with the PTH\PTHrP receptor in TEC suggests that PTHrP has the potential for exerting important intrathymic effects. Therefore, while the identification of specific roles for PTHrP in thymic development or function must await further evaluation, these initial studies suggest that PTHrP that may be one additional factor whose production within the important epithelial microenvironment of the thymus may influence thymic function and, therefore, the development of cellular immunity.
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